Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NPA gets permanent CEO/exec director

This article was originally published in The Tan Sheet

Executive Summary

The Natural Products Association Oct. 22 names John Gay as its executive director and CEO. NPA President Pat Sardell said Gay's 25 years of working in Washington on policy issues make him "the ideal person for the job." Gay was most recently senior VP of government affairs and public policy for the National Restaurant Association. He also has nonprofit experience and worked as a Senate staffer. Gay will begin the job before the group's Nov. 2 board meeting. Daniel Fabricant, NPA's VP of scientific and regulatory affairs, filled the position on an interim basis after David Seckman departed in July (1"The Tan Sheet" June 15, 2009)

You may also be interested in...



Seckman leaves NPA

David Seckman parts ways with the Natural Products Association at the end of July after nine years as executive director to head up the Food Processing Suppliers Association. While with NPA, Seckman "made significant contributions that leave us in an excellent position to continue to meet member needs well into the future," NPA President Debra Short says in a June 11 release. NPA says it will form a search committee to work with a recruitment firm

Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation

Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.

‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports

The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103465

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel